HO

Hari Om Sharma

Active Director Director DIN 03405983
DIN 03405983 First appointment Mar 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Mar 2011
Shareholding value •••• Premium profile

About Hari Om Sharma

Data last updated:

Hari Om Sharma is a Director at Chemsynth Drugs & Pharmaceuticals Private Limited (since 2011), Director at Vicint Biosciences Private Limited (since 2019) and Director at Alchemist Chemsynth Pharma Private Limited (since 2018). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹70.37 Cr; the largest is Chemsynth Drugs & Pharmaceuticals Private Limited at ₹70.25 Cr (FY 2024). Earlier, Hari Om Sharma was a Director at Kalpro Alliances Private Limited (2018–2023) and Director at Scientific Agencies Private Limited (2016–2017) and 1 more.

DIN 03405983
Primary Designation Director
Industry Pharma
First Appointment 01 Mar 2011
Oldest Company Age 15 yrs
Largest company Chemsynth Drugs & Pharmaceuticals Private Limited · ₹70.25 Cr (FY 2024)
Combined revenue ₹70.37 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20112011₹70.25 Cr (FY 2024)Active
Vicint Biosciences Private Limited U24304DL2019PTC347613
Director25 Mar 20192019₹6.4 Lakh (FY 2025)Active
Director18 May 20182018₹5.8 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kalpro Alliances Private Limited U24111DL2018PTC339621
Director27 Sep 20182018₹16.94 Cr (FY 2024)Active
Scientific Agencies Private Limited U52190HR1996PTC033319
Director01 Jan 20161996₹19.50 Cr (FY 2024)Active
Director25 Jun 20192019₹71.8 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chemsynth Drugs & Pharmaceuticals Private Limited
Alchemist Chemsynth Pharma Private Limited
Vicint Biosciences Private Limited
Kalpro Alliances Private Limited
Premium access

Shareholding and investment profile for Hari Om Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hari Om Sharma

Hari Om Sharma currently holds 3 directorships: Chemsynth Drugs & Pharmaceuticals Private Limited (Director, since 01 Mar 2011, revenue ₹70.25 Cr (FY 2024)); Vicint Biosciences Private Limited (Director, since 25 Mar 2019, revenue ₹6.4 Lakh (FY 2025)); Alchemist Chemsynth Pharma Private Limited (Director, since 18 May 2018, revenue ₹5.8 Lakh (FY 2025)).

Hari Om Sharma was first appointed on 01 Mar 2011 as Director at Chemsynth Drugs & Pharmaceuticals Private Limited. The most recent appointment on record is 25 Jun 2019 at Lucon Pharma And Research Private Limited.

The 3 current companies of Hari Om Sharma that report revenue have a combined latest revenue of ₹70.37 Cr: Chemsynth Drugs & Pharmaceuticals Private Limited ₹70.25 Cr (FY 2024); Vicint Biosciences Private Limited ₹6.4 Lakh (FY 2025); Alchemist Chemsynth Pharma Private Limited ₹5.8 Lakh (FY 2025).

Hari Om Sharma held 3 earlier board appointments: Kalpro Alliances Private Limited (Director, 27 Sep 2018 to 28 Mar 2023); Scientific Agencies Private Limited (Director, 01 Jan 2016 to 14 Aug 2017); Lucon Pharma And Research Private Limited (Director, 25 Jun 2019 to 15 Dec 2019).

The current boards of Hari Om Sharma's companies include Kusum Sharma (Chemsynth Drugs & Pharmaceuticals Private Limited), Krishan Tyagi (Vicint Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available